SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-Q 10-Q 8/9/2017 6/30/2017
Insider Ownership 4 7/12/2017 7/10/2017
Abstract: ROSENWALD LINDSAY A MD
8-K 8-K 6/27/2017 6/26/2017
Abstract: 8-K filed by Checkpoint Therapeutics (CKPT) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing and Financial Statements and Exhibits.
Registration Statement 8-A12B 6/22/2017
Abstract: Registrant filed a description of its common stock, incorporated by reference into its registration statement on Form 10, in order to register it under the Securities Exchange Act of 1934.
8-K 8-K 6/20/2017 6/14/2017
Abstract: 8-K filed by Checkpoint Therapeutics (CKPT) covering Submission of Matters to a Vote of Security Holder.
Insider Ownership 4 6/15/2017 6/15/2017
Abstract: SALZMAN BARRY M
Insider Ownership 4 6/15/2017 6/15/2017
Abstract: Herskowitz Neil
Insider Ownership 4 6/15/2017 6/15/2017
Abstract: Boilen Scott
Insider Ownership 4 6/15/2017 6/15/2017
Abstract: WEISS MICHAEL S
Insider Ownership 4 6/7/2017 3/17/2017
Abstract: Fortress Biotech, Inc.
Insider Ownership 3 6/7/2017 9/8/2016
Abstract: Fortress Biotech, Inc.
13-D SC 13D 5/26/2017
10-Q 10-Q 5/10/2017 3/31/2017
Proxy DEF 14A 4/28/2017 6/14/2017
10-K 10-K/A 3/21/2017 12/31/2016
Registration Statement S-8 3/21/2017
Registration Statement S-1 3/21/2017
10-K 10-K 3/17/2017 12/31/2016
Insider Ownership 4 1/19/2017 1/13/2017
Abstract: Herskowitz Neil
8-K 8-K 1/6/2017 12/30/2016
Abstract: 8-K filed by Checkpoint Therapeutics (CKPT) covering Entry into a Material Definitive Agreement.

Displaying 1 to 20 (of 46 filings)